Literature DB >> 8566105

The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.

M I Colado1, A R Green.   

Abstract

Administration of a single dose (10 mg/kg i.p.) of 3,4-methylenedioxy-methamphetamine (MDMA or 'ecstasy') produced a 40% loss of 5-hydroxytryptamine (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in cortex and hippocampus of Dark Agouti rats 7 days later. Binding of [3H]paroxetine to the presynaptic 5-HT nerve terminals in cortex was decreased by approximately 30%. Injection of the spin trap reagent alpha-phenyl-N-tert-butyl nitrone (PBN; 150 mg/kg i.p.) 10 min prior and 120 min post MDMA administration totally prevented the loss in [3H]paroxetine binding in the cortex and attenuated the loss of 5-HT and 5-HIAA in both brain regions. PBN alone had no effect on [3H]paroxetine binding or brain 5-HT content. These data suggest that MDMA produces neurodegeneration of 5-HT neurones because of reactive free radical formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566105     DOI: 10.1016/0014-2999(95)00298-y

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.

Authors:  Joseph M Breier; Michael G Bankson; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 2.  Causes and consequences of methamphetamine and MDMA toxicity.

Authors:  Maria S Quinton; Bryan K Yamamoto
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

3.  Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes.

Authors:  Sylvia K Shenouda; Kurt J Varner; Felix Carvalho; Pamela A Lucchesi
Journal:  Cardiovasc Toxicol       Date:  2009-03-31       Impact factor: 3.231

Review 4.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

5.  Initial deficit and recovery of function after MDMA preexposure in rats.

Authors:  K A Brennan; S Schenk
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

6.  Ecstasy and neurodegeneration.

Authors:  A R Green; G M Goodwin
Journal:  BMJ       Date:  1996-06-15

Review 7.  Mechanisms of methamphetamine-induced dopaminergic neurotoxicity.

Authors:  Evan L Riddle; Annette E Fleckenstein; Glen R Hanson
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

8.  Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryls that spare the enzyme iron center.

Authors:  D M Kuhn; R Arthur
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

9.  Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake.

Authors:  Courtney Huff; Nirmal Bhide; Allen Schroering; Bryan K Yamamoto; Gary A Gudelsky
Journal:  Brain Res Bull       Date:  2013-01-12       Impact factor: 4.077

Review 10.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.